Furthermore, evidences are also focusing on downstream effects of antioxidants in terms of activation-repression of transcription factors such as CREB or Nrf2, making of antioxidant therapies a good tool against neural and functional alterations in diabetes and alcohol-related memory or cognitive impairments. The gene discussed is CREB1; the disease is diabetes mellitus.